Interventional glaucoma and the patient perspective

Abstract

Introduction The glaucoma treatment paradigm is beginning to undergo a reevaluation – one that promotes a proactive approach with minimally invasive intervention(s) instead of the traditional reactive strategy that leaves patients on topical eyedrops and allows for progressive decline in ocular health before intervening further. Earlier low-risk interventions may include laser, minimally invasive glaucoma surgery (MIGS), and/or procedural pharmaceuticals.